环丙甲酸叔丁酯, ≥98%|tert-Butyl Cyclopropanecarboxylate|cas:87661-20-9|西域试剂

环丙甲酸叔丁酯, ≥98%,tert-Butyl Cyclopropanecarboxylate

产品编号：西域试剂-WR192714| CAS NO：87661-20-9| MDL NO：MFCD09836696| 分子式：C₈H₁₄O₂| 分子量：142.20

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	价格	库存与货期
西域试剂-WR192714	￥65.00	杭州北京（现货）
西域试剂-WR192714	￥224.00	杭州北京（现货）
西域试剂-WR192714	￥1017.00	杭州北京（现货）
西域试剂-WR192714	￥2975.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

英文名称	tert-Butyl Cyclopropanecarboxylate
CAS编号	87661-20-9
产品沸点	148.8±8.0 °C at 760 mmHg
产品密度	1.0±0.1 g/cm3
产品闪点	41.1±6.0 °C
精确质量	142.099380
PSA	26.30000
LogP	1.77
蒸气压	4.2±0.3 mmHg at 25°C
折射率	1.463

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品

CAS号：87661-20-9

环丙甲酸叔丁酯, ≥98%

￥65.00

海关编码	2916209090

Material Safety Data Sheet

Section1. Identiﬁcation of the substance
Product Name: tert-Butyl cyclopropanecarboxylate
Synonyms:

Section2. Hazards identiﬁcation
Harmful by inhalation, in contact with skin, and if swallowed.

Section3. Composition/information on ingredients.
Ingredient name:tert-Butyl cyclopropanecarboxylate
CAS number:87661-20-9

Section4. First aid measures
Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
ﬂushing of the eyes by separating the eyelids with ﬁngers. If irritation persists, seek medical
attention.
Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section5. Fire ﬁghting measures
In the event of a ﬁre involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution:Wear approved mask/respirator
Hand precaution:Wear suitable gloves/gauntlets
Skin protection:Wear suitable protective clothing
Eye protection:Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section7. Handling and storage
Handling:This product should be handled only by, or under the close supervision of, those properly qualiﬁed
in the handling and use of potentially hazardous chemicals, who should take into account the ﬁre,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section9. Physical and chemical properties
Appearance:Not speciﬁed
Boiling point:No data
No data
Melting point:
Flash point:No data
Density:No data
Molecular formula:C8H14O2
Molecular weight:142.2

Section10. Stability and reactivity
Conditions to avoid: Heat, ﬂames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section11. Toxicological information
No data.

Section12. Ecological information
No data.

Section13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section14. Transportation information
Non-harzardous for air and ground transportation.

Section15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

SECTION 16 - ADDITIONAL INFORMATION
N/A

865-47-4

4023-34-1

~90%

87661-20-9

文献：Aebi, Johannes; Binggeli, Alfred; Green, Luke; Hartmann, Guido; Maerki, Hans P.; Mattei, Patrizio; Ricklin, Fabienne; Roche, Olivier Patent: US2010/16282 A1, 2010 ; Location in patent: Page/Page column 19 ;

75-65-0

1759-53-1

~59%

87661-20-9

文献：KAREUS THERAPEUTICS, SA Patent: US2012/71528 A1, 2012 ; Location in patent: Page/Page column 11-12 ;

866463-77-6

~82%

87661-20-9

文献：DAIICHI PHARMACEUTICAL CO., LTD. Patent: EP1731499 A1, 2006 ; Location in patent: Page/Page column 14 ;

4023-34-1

75-65-0

87661-20-9

文献：Kohlrausch; Skrabal Monatshefte fuer Chemie, 1937 , vol. 70, p. 392,393 Zeitschrift fuer Elektrochemie und Angewandte Physikalische Chemie, 1937 , vol. 43, p. 283

3153-32-0

~75%

87661-20-9

文献：Makosza, Mieczyslaw; Judka, Marek Chemistry - A European Journal, 2002 , vol. 8, # 18 p. 4234 - 4240

4023-34-1

87661-20-9

文献：NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2005/51911 A1, 2005 ; Location in patent: Page/Page column 73 ; WO 2005/051911 A1

144-55-8

75-65-0

1759-53-1

87661-20-9

文献：Pfizer Inc Patent: US2005/187266 A1, 2005 ;

上游产品 7
865-47-4 4023-34-1 75-65-0 1759-53-1
866463-77-6 3153-32-0 144-55-8
下游产品 0